Physician

John Brandon Davies, MD

According to 2025 Medicare claims, John Davies, MD (NPI: 1811904212) practices ophthalmology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Hennepin, MN. This provider's primary affiliated billing organization is VITREO RETINAL SURGERY PLLC (NPI: 1891783965; TIN: 411608615) and primary practice location at 55435-3004.

Davies' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,079 traditional Medicare patients, billed 53,032 HCPCS/CPT codes, and received $4,753,311 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 1,152 prescription claims across 364 beneficiaries totaling $60,176 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 6 records totaling $215,725. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,393,527 to $4,753,311. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.4M$4.8M2015 Medicare payment: $1,393,527 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,536,152 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,866,815 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,413,396 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,279,791 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,608,012 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,883,984 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,791,458 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,973,045 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,753,311 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157309,424$1,393,527
20167129,778$1,536,152
201786210,803$1,866,815
201886912,752$2,413,396
20191,19021,967$4,279,791
20201,01318,971$3,608,012
20211,11519,956$3,883,984
20221,04218,391$3,791,458
20231,02644,945$3,973,045
20241,07953,032$4,753,311

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$44K$88K2015 Drug cost: $88,375 (USD; Tot_Drug_Cst)2016 Drug cost: $79,790 (USD; Tot_Drug_Cst)2017 Drug cost: $70,840 (USD; Tot_Drug_Cst)2018 Drug cost: $84,372 (USD; Tot_Drug_Cst)2019 Drug cost: $71,478 (USD; Tot_Drug_Cst)2020 Drug cost: $62,536 (USD; Tot_Drug_Cst)2021 Drug cost: $68,488 (USD; Tot_Drug_Cst)2022 Drug cost: $67,279 (USD; Tot_Drug_Cst)2023 Drug cost: $73,012 (USD; Tot_Drug_Cst)2024 Drug cost: $60,176 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152441,031$88,375
20162801,070$79,790
20173071,109$70,840
20183161,200$84,372
20193411,187$71,478
20202841,129$62,536
20213241,137$68,488
2022308960$67,279
2023306909$73,012
20243641,152$60,176

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2431,856$658
67028Injection of drug into eye5722,310$97
92014Established patient complete exam of visual system352423$94
92012Established patient problem focused exam of visual system492758$68
92134Imaging of retina1,0553,211$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate27215,744$13,891
ProlensaBromfenac Sodium29904$10,559
Bromfenac SodiumBromfenac Sodium542,016$9,566
Ketorolac TromethamineKetorolac Tromethamine1588,669$3,624
Brimonidine TartrateBrimonidine Tartrate664,067$2,701

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.0$0N/R
Research PaymentsReported research-related payment or transfer-of-value amount.6$215,725EyePoint Pharmaceuticals US, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John Brandon Davies, MD?

Tedicare shows public-source Medicare data for John Brandon Davies, MD (NPI 1811904212), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Brandon Davies, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Brandon Davies, MD?

John Brandon Davies, MD is linked to VITREO RETINAL SURGERY PLLC (billing NPI 1891783965) in the available physician profile data.

Does John Brandon Davies, MD have Open Payments data?

John Brandon Davies, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.